GovChime
Notice ID: 37b4bd89b3ee465f9e9062df2ace47a1Award NoticeAwarded

Blood Donor Screening Tests approved by FDA for Blood Donations - US Naval Hospital Okinawa, Japan

Awarded on February 27, 2024. Full description on SAM.gov.

Awarded tounder HT941024P0103 (source: SAM.gov award notice)• $787.8K

Overview

Posted
February 28, 2024
Notice type
Award Notice
NAICS
325413: In-Vitro Diagnostic Substance Manufacturing
Agency
Department of War

Notice details

PSC
6550: IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
Last updated
Dec 4, 2025
Award date
Feb 27, 2024
Award amount (SAM.gov award notice)
$787.8K

Identifiers

Solicitation number
HT941024Q2024
Notice ID
37b4bd89b3ee465f9e9062df2ace47a1
Award number (PIID)
HT941024P0103

Description

A firm fixed price contract was awarded to BLOODWORKS for Blood Donor Screening Tests on 27 FEBRUARY 2024. Total Contract value is $2,482,404.00.

Full description on SAM.gov

Award Overview

Award Number

HT941024P0103

Award Amount (SAM.gov award notice)

$787.8K

Award Date

Feb 27, 2024

Awardee

Awardee UEI

ZN56PFWUDQK7

Original Solicitation

Notice ID: 37b4bd89b3ee465f9e9062df2ace47a1

Posted Date: Feb 28, 2024

Original Response Deadline: Not specified

More From This Vendor

Top 5 most recent

1
  • HT940622P0003
    BLOODWORKS
    Department of DefenseNAICS 325413
    $156.9KSigned Jun 25, 2025

Contacts

Documents

No documents available.

Lifecycle

Solicitation:HT941024Q2024
  1. Combined Synopsis
  2. Awarded

This opportunity has been awarded.

  1. 2×
    Combined SynopsisFeb 20, 2024

    Blood Donor Screening Tests approved by FDA for Blood Donations - US Naval Hospital Okinawa, Japan

    Notice fb16c4767b1748b8864f4e9c8920f100 on SAM.gov

  2. AwardedCurrentFeb 28, 2024

    Blood Donor Screening Tests approved by FDA for Blood Donations - US Naval Hospital Okinawa, Japan

    Notice 37b4bd89b3ee465f9e9062df2ace47a1 on SAM.gov

Similar Opportunities

Title
Phase
Deadline
Phadia 250 Reagent and Consumables
AwardedOpen
DLA – TS E&A, in conjunction with the United States Army Medical Materiel Center-Europe (USAMMCE), is conducting market research to support the recompete of its commercial laboratory supplies contract. The resulting contract will provide clinical laboratory reagents, test cartridges, calibrators, controls, and associated consumables that operate in conjunction with specific Government-owned laboratory analyzers and capital equipment (e.g., Abbott i-STAT, Siemens DCA 2000, and other point-of-care or automated platforms). The primary ordering activity and logistics hub is USAMMCE, servicing Department of Defense (DoD) medical treatment facilities and operational forces across the European Command (EUCOM) and possibly Central Command (CENTCOM) theaters. The follow-on ordering period is projected to commence on 15 January 2028.
Market Research10/30/2026
This requirement for reagents, quality control, maintenance, consumables, and two (2) automated urine laboratory analyzers for use at United States Naval Health Clinic Hawaii (NHCH) Makalapa and Branch Health Clinic Kaneohe Bay was awarded as a firm-fixed-price, sole source, supply contract to Beckman Coulter, Inc. pursuant to FAR Subpart 13.5 and in accordance with 41 U.S.C. 1901 Simplified Acquisition Procedures after receiving no additional information from interested parties in response to Notice of Intent to Sole Source HT941023N0020.
AwardedOpen
Attached is the award for Trazodone.
AwardedOpen
Sole Source / J&AOpen

Additional Details

Solicitation Number

HT941024Q2024

Archive Date

Mar 13, 2024

Place of Performance Country

JPN

Office Address

FALLS CHURCH, VA, 22042